This is not the most recent version of the article. View current version (15 APR 2014)

Intervention Review

Treatment for amphetamine dependence and abuse

  1. Manit Srisurapanont1,*,
  2. Ngamwong Jarusuraisin2,
  3. Phunnapa Kittirattanapaiboon3

Editorial Group: Cochrane Drugs and Alcohol Group

Published Online: 23 OCT 2001

Assessed as up-to-date: 1 AUG 2001

DOI: 10.1002/14651858.CD003022


How to Cite

Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment for amphetamine dependence and abuse. Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD003022. DOI: 10.1002/14651858.CD003022.

Author Information

  1. 1

    Chiang Mai University, Department of Psychiatry, Chiang Mai 50202, Thailand

  2. 2

    Chiang Mai University, Department of Psychiatry, Amphur Muang, Chiang Mai, Thailand

  3. 3

    Suanprung Psychiatric Hospital, Psichiatry, Amphur Muang, Chiang Mai, Thailand

*Manit Srisurapanont, Department of Psychiatry, Chiang Mai University, P.O. Box 102, Amphur Muang, Chiang Mai 50202, Thailand. msrisura@mail.med.cmu.ac.th.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 OCT 2001

SEARCH

This is not the most recent version of the article. View current version (15 APR 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Louisa Degenhardt, Amanda J. Baxter, Yong Yi Lee, Wayne Hall, Grant E. Sara, Nicole Johns, Abraham Flaxman, Harvey A. Whiteford, Theo Vos, The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010, Drug and Alcohol Dependence, 2014, 137, 36

    CrossRef

  2. 2
    S. Wayne Miles, Janie Sheridan, Bruce Russell, Rob Kydd, Amanda Wheeler, Carina Walters, Greg Gamble, Peta Hardley, Maree Jensen, Kimmo Kuoppasalmi, Pekka Tuomola, Jaana Föhr, Outi Kuikanmäki, Helena Vorma, Raimo Salokangas, Antti Mikkonen, Mika Kallio, Jussi Kauhanen, Vesa Kiviniemi, Jari Tiihonen, Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial, Addiction, 2013, 108, 7
  3. 3
    Louisa Degenhardt, Harvey A Whiteford, Alize J Ferrari, Amanda J Baxter, Fiona J Charlson, Wayne D Hall, Greg Freedman, Roy Burstein, Nicole Johns, Rebecca E Engell, Abraham Flaxman, Christopher JL Murray, Theo Vos, Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010, The Lancet, 2013, 382, 9904, 1564

    CrossRef

  4. 4
    Karl Mann, Michael M. Berner, Arthur Günthner, Psychische Erkrankungen, 2012,

    CrossRef

  5. 5
    Jenny Häggkvist, Carl Björkholm, Pia Steensland, Sara Lindholm, Johan Franck, Björn Schilström, Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat, Addiction Biology, 2011, 16, 1
  6. 6
    Todd Zorick, Liam Nestor, Karen Miotto, Catherine Sugar, Gerhard Hellemann, Graham Scanlon, Richard Rawson, Edythe D. London, Withdrawal symptoms in abstinent methamphetamine-dependent subjects, Addiction, 2010, 105, 10
  7. 7
    Clara Pérez-Mañá, Xavier Castells, Marta Torrens, Dolors Capellà, Magi Farre, Efficacy of Psychostimulant Drugs for Amphetamine Abuse or Dependence, The Cochrane Library,
  8. 8
    BGO Soares, MS Lima, M Farrell, Psychosocial treatments for psychostimulants dependence, The Cochrane Library,